Sublingual tacrolimus: A pharmacokinetic evaluation pilot study

Pharmacotherapy

Volumn 33, Issue 1, 2013, Pages 31-37

  Tsapepas, Demetra ^a   Saal, Stuart ^b,c   Benkert, Steven ^b   Levine, Daniel ^c   Delfin, Merdie ^b   Cremers, Serge ^d   Amann, Shawn ^c   Dadhania, Darshana ^b,c   Kapur, Sandip ^b   Aull, Meredith ^b  

^a Department of Medicine   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c ROGOSIN INSTITUTE   (United States)

^d Columbia University ^*  (United States)

Author keywords

Immunosuppression; Pharmacokinetics; Renal transplantation; Sublingual; Tacrolimus

Indexed keywords

CLOTRIMAZOLE; NYSTATIN; TACROLIMUS;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; DEMOGRAPHY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG METABOLISM; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MAXIMUM PLASMA CONCENTRATION; OPEN STUDY; PARALLEL DESIGN; PILOT STUDY; PLASMA CONCENTRATION-TIME CURVE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STEADY STATE; TIME TO MAXIMUM PLASMA CONCENTRATION; UNIVERSITY HOSPITAL; VENOUS BLOOD;

ADMINISTRATION, ORAL; ADMINISTRATION, SUBLINGUAL; ADULT; AGED; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; TACROLIMUS;

EID: 84875473713     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1002/phar.1149     Document Type: Article

References (17)

1. Plosker GL, Foster RH. Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation. Drugs 2000;59(2):323-89.
2. Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet 2004;43(10):623-53.
3. Venkataramanan R, Jain A, Cadoff E, et al. Pharmacokinetics of FK 506: preclinical and clinical studies. Transplant Proc 1990;22(1):52-6.
4. Venkataramanan R, Swaminathan A, Prasad T, et al. Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet 1995; 29(6):404-30.
5. Dirks NL, Huth B, Yates CR, Meibohm B. Pharmacokinetics of immunosuppressants: a perspective on ethnic differences. Int J Clin Pharmacol Ther 2004;42(12):701-18.
6. Motwani JG, Lipworth BJ. Clinical pharmacokinetics of drug administered buccally and sublingually. Clin Pharmacokinet 1991;21(2):83-94.
7. Zhang H, Zhang J, Streisand JB. Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clin Pharmacokinet 2002;41(9):661-80.
8. Reams D, Rea J, Davis D, Palmer S. Utility of sublingual tacrolimus in cystic fibrosis patients after lung transplantation. J Heart Lung Transplant 2001;20(2):207-8.
9. Romero I, Jimenez C, Gil F, et al. Sublingual administration of tacrolimus in a renal transplant patient. J Clin Pharm Ther 2008;33(1):87-9.
10. Collin C, Boussaud V, Lefeuvre S, et al. Sublingual tacrolimus as an alternative to intravenous route in patients with thoracic transplant: a retrospective study. Transplant Proc 2010; 42(10):4331-7.
11. Reams BD, Palmer SM. Sublingual tacrolimus for immunosuppression in lung transplantation: a potentially important therapeutic option in cystic fibrosis. Am J Respir Med 2002;1(2):91-8.
12. van de Plas A, Dackus J, Christiaans MH, Stolk LM, van Hooff JP, Neef C. A pilot study on sublingual administration of tacrolimus. Transpl Int 2009;22(3):358-9.
13. Amann S, Parker TS, Levine DM. Evaluation of 2 immunoassays for monitoring low blood levels of tacrolimus. Ther Drug Monit 2009;31(2):273-6.
14. Seo M, iida H, Miura Y. Basic experiments with clotrimazole administered orally. Curr Med Res Opin 1977;5(2):169-78.
15. Kagayama A, Tanimoto S, Fujisaki J, et al. Oral absorption of FK506 in rats. Pharm Res 1993;10(10):1446-50.
16. Vasquez E, Pollak R, Benedetti E. Clotrimazole increases tacrolimus blood levels: a drug interaction in kidney transplant patients. Clin Transplant 2001;15(2):95-9.
17. Vasquez EM, Shin GP, Sifontis N, Benedetti E. Concomitant clotrimazole therapy more than doubles the relative oral bioavailability of tacrolimus. Ther Drug Monit 2005;27(5):587-91.